Projects per year
Project Details
Description
The Rare Cancers Research Group explores the molecular mechanisms associated with cancerogenesis and tumour progression focusing on rare cancers. We aim to identify novel cancer-specific biomarkers and ultimately improve diagnostics and therapies. We are determined to pave the way towards precision medicine to effectively treat rare cancers.
| Acronym | RaCaRe |
|---|---|
| Status | Not started |
Funding
- Sarcoma Foundation of America: €41,260.00
Projects
- 1 Finished
-
Uudet ennustetekijät ja lääkekohteet pahanlaatuisissa liposarkoomissa
Sihto, H., Jaatinen, J. K., O'Dell, P. & Salmikangas, S. I.
01/01/2017 → 31/12/2019
Project: University of Helsinki Three-Year Research Project
Research output
- 1 Article
-
ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival
Jaatinen, J., Veija, T., Salmikangas, M., Bohling, T., Sihto, H. & Koljonen, V., 24 May 2021, In: PLoS One. 16, 5, 13 p., 0252099.Research output: Contribution to journal › Article › Scientific › peer-review